Effects of Legume Intake on Cardiovascular Risk Factors Among Adults at Risk for Diabetes
1 other identifier
interventional
26
1 country
1
Brief Summary
This randomized cross-over study was designed to investigate the effects of legume enriched diet consumption on cardiovascular risk factors among first degree relatives of diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Sep 2012
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 9, 2013
CompletedFirst Posted
Study publicly available on registry
July 23, 2013
CompletedJuly 23, 2013
July 1, 2013
4 months
July 9, 2013
July 18, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Fasting blood glucose (mg/dl)
amounts of FBG
14 weeks
Secondary Outcomes (5)
Hemoglobin A1C (%)
14 weeks
Total cholesterol (mg/dl)
14 weeks
Low Density Lipoprotein (mg/dl)
14 weeks
High Density Lipoprotein (mg/dl)
14 weeks
Triglyceride (mg/dl)
14 weeks
Study Arms (2)
legume enriched diet
EXPERIMENTALlegume consumption, 4 servings per week, for 6 weeks
healthy dietary recommendations
ACTIVE COMPARATORno nutritional intervention
Interventions
Eligibility Criteria
You may qualify if:
- subjects aged more than 30 years
- no history of chronic diseases
- no use of blood glucose lowering drugs be wiling to participate to study
You may not qualify if:
- do not follow study protocol
- incidence of chronic diseases during the study
- to start use of blood glucose lowering drugs or to change dose and type of current medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Isfahan University of Medical Sciences
Isfahan, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Isfahan University of Medical Sciences
Study Record Dates
First Submitted
July 9, 2013
First Posted
July 23, 2013
Study Start
September 1, 2012
Primary Completion
January 1, 2013
Study Completion
March 1, 2013
Last Updated
July 23, 2013
Record last verified: 2013-07